Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Vomiting 4Nausea 4Fatigue 4Hematopoietic and Lymphatic System Neoplasm 3Breast Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Pain 2Neoplasms 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Anxiety Disorders 2Syndrome 1Supportive Care 1Stomach Neoplasms 1Rectal Neoplasms 1Radiation Injuries 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Gastrointestinal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Dyspnea 1Disease 1Depression 1Cough 1Colonic Neoplasms 1

Interventions

Temozolomide 393Radiotherapy 196Bevacizumab 156Radiation 77Magnetic Resonance Spectroscopy 68Lomustine 47Surgical Procedures, Operative 42Carmustine 41pembrolizumab 39Irinotecan 38Nivolumab 32Specimen Handling 27Carboplatin 27Radiosurgery 24Erlotinib Hydrochloride 24Chemotherapy, Adjuvant 23Radiotherapy, Intensity-Modulated 22Drug Therapy 21Cyclophosphamide 20Aminolevulinic Acid 20O(6)-benzylguanine 17sargramostim 16Radiotherapy, Conformal 15temsirolimus 14Granulocyte-Macrophage Colony-Stimulating Factor 14Everolimus 14Vorinostat 13Sorafenib 13poly ICLC 12atezolizumab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Glioblastoma × Acupressure × Clear all
NCT03185780 2018-11-28

Complementary/Integrative Medicine for Brain Cancer Patients

The Chaim Sheba Medical Center

Phase NA Withdrawn
CNS

Glioblastoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡